Comparison of VTE prophylaxis agents on hemoglobin levels after total knee arthroplasty: a hospital information system-based observational study
Single-center retrospective cohort study published in Journal of orthopaedic surgery and research (2025)
Resumen
BACKGROUND: While venous thromboembolism (VTE) prophylaxis is crucial following major orthopaedic surgeries including total knee arthroplasty (TKA), the impact of different prophylactic agents on postoperative hemoglobin (Hb) levels remains inadequately studied. The aim of this study was to compare the effects of aspirin, rivaroxaban, and low-molecular-weight heparin (LMWH) on early postoperative Hb changes following TKA. METHODS: In this single-center retrospective cohort study, 655 primary TKAs were finally included using data from the hospital information system. Patients received either aspirin, rivaroxaban, or LMWH for VTE prophylaxis. The primary outcome was the magnitude of Hb reduction, calculated as the difference between the Hb level on the first postoperative day and the minimum postoperative Hb level before discharge. The secondary outcome was the trajectory of postoperative Hb changes within the first week. RESULTS: Postoperative Hb levels clearly declined within the first week, with a mean of 13.9 g/L (SD, 8.5) from postoperative day 1 in the entire cohort. In the fully adjusted linear regression model, both rivaroxaban (β = 1.5, [95%CI, 0.0 to 3.0]) and low-molecular-weight heparin (LMWH) (β = 3.3, [95%CI, 1.5 to 5.2]) were associated with a greater reduction in Hb compared to aspirin. Regarding the trajectory of postoperative Hb changes, the generalized additive mixed model revealed no statistically significant difference between rivaroxaban and aspirin (β = -0.2, [95%CI, -0.6 to 0.2]). LMWH was associated with a greater daily reduction in Hb levels relative to aspirin, averaging 0.8 g/L per day (β = -0.8, [95%CI, -1.3 to -0.3]). Despite these observed differences, the effect sizes were small, suggesting a lack of clinical significance. CONCLUSIONS: Hemoglobin levels declined significantly following TKA within the first week after surgery. However, no clinically meaningful distinction is discernible between the three most frequently used pharmacological agents, aspirin, rivaroxaban and LMWH. LEVEL OF EVIDENCE: III, A retrospective cohort study.
Resumen tomado de PubMed (NCBI) para el registro citado, en el idioma original. La versión de referencia es la de la publicación original.
El resumen se deja sin traducir para conservar la redacción original de los autores.
Síntesis
In 655 total knee arthroplasty patients, postoperative hemoglobin declined by a mean 13.9 g/L within the first week, with rivaroxaban and low-molecular-weight heparin associated with greater reductions than aspirin, though effect sizes were small.
Por qué esto importa para la hirudoterapia
Esta cohorte retrospectiva de un solo centro de 655 artroplastias totales de rodilla primarias comparó la aspirina, el rivaroxaban y la heparin de bajo peso molecular (LMWH) para la profilaxis de VTE, midiendo el descenso temprano de la hemoglobina posoperatoria; aunque el rivaroxaban y la LMWH se asociaron estadísticamente con una reducción de Hb ligeramente mayor que la aspirina, los autores consideraron que los tamaños del efecto fueron pequeños y concluyeron que no hubo una diferencia clínicamente significativa entre los tres agentes. Para la hirudoterapia, el estudio proporciona un contexto útil sobre el equilibrio entre el sangrado y la pérdida de sangre de los anticoagulantes sistémicos en los mismos entornos quirúrgicos y de congestión microvascular donde el uso de sanguijuelas medicinales se emplea a veces como un complemento local en lugar de un anticoagulante sistémico. Al ser una cohorte retrospectiva de un solo centro calificada como evidencia de Nivel III por los autores, muestra asociación en lugar de causalidad, examina únicamente la profilaxis farmacológica y no dice nada directamente sobre la terapia con sanguijuelas.
Compuestos relacionados del registro de la ASH
Fármacos sintéticos relacionados con el tema de este artículo. Actúan sobre las mismas dianas que las moléculas de la sanguijuela, pero no se derivan de la sanguijuela:
Citación
Comparison of VTE prophylaxis agents on hemoglobin levels after total knee arthroplasty: a hospital information system-based observational study.
Yuan et al. · Journal of orthopaedic surgery and research, 2025
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Investigación relacionada
Más estudios revisados por pares en la categoría «Seguridad y control de infecciones».
- Leech-Assisted Flap Salvage — Systematic Review of 277 Cases — Whitaker et al. (2012)
- Effects of hirudotherapy on liver functions, lipid profile, and insulin sensitivity in rats with metabolic syndrome — Bilden A et al. (2026)
- Efficacy and Safety of Hirudotherapy for Improving Sperm Quality Parameters in Male Infertility: A Randomized Controlled Trial — Abtahi-Forooshani M et al. (2026)
- Improvement of patient care through hirudotherapy and the management of leeches from their reception to their disposal in France — Vaesken C et al. (2023)
- Hirudotherapy in Medicine and Dentistry — Jha K et al. (2015)
- Management of Chronic Non-healing Wounds by Hirudotherapy — Iqbal A et al. (2017)
- La hirudoterapia atenúa el dolor artrítico en pacientes con diversos síndromes de dolor crónico: un análisis retrospectivo — Loeser J et al. (2020)
- Hirudotherapy (medicinal leeches) for treatment of upper airway obstruction in a dog — Trenholme H, Masseau I, Reinero C (2021)
- Análisis de infecciones resistentes a antibióticos asociadas a la hirudoterapia — Brauer P et al. (2024)
- ¡Déjame en paz, sanguijuela! Hemartrosis atraumática tras hirudoterapia — Curcio J, Lloyd C (2020)
Añadido a la biblioteca ASH: 29 de mayo de 2026 · Última actualización del sitio: 18 de junio de 2026